DNA diagnosis and clinical manifestations of autosomal dominant polycystic kidney disease
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
9595261
Knihovny.cz E-resources
- MeSH
- Child MeSH
- Genes, Dominant MeSH
- Adult MeSH
- Hypertension complications MeSH
- TRPP Cation Channels MeSH
- Creatinine blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Membrane Proteins genetics MeSH
- Microsatellite Repeats MeSH
- Adolescent MeSH
- Polycystic Kidney, Autosomal Dominant diagnosis epidemiology genetics MeSH
- Polymorphism, Restriction Fragment Length MeSH
- Child, Preschool MeSH
- Proteins genetics MeSH
- Aged MeSH
- Age Factors MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic epidemiology MeSH
- Names of Substances
- TRPP Cation Channels MeSH
- Creatinine MeSH
- Membrane Proteins MeSH
- polycystic kidney disease 1 protein MeSH Browser
- polycystic kidney disease 2 protein MeSH Browser
- Proteins MeSH
At least 2 genes, detectable by DNA methods, encode autosomal dominant polycystic kidney disease (ADPKD), which remains the most frequent and serious hereditary renal disease. PKD1 gene, localized on chromosome 16, responds for the clinical course in the majority of ADPKD patients, whereas PKD2 gene, localized on chromosome 4, is responsible for less than 10-15% of cases, with presumed milder phenotypic manifestations. To start the clinical and genetic correlation in patients with different genotypes (PKD1 vs. PKD2) in the Czech population, a pilot group of 88 patients with ADPKD was analysed. Families with PKD1 (n = 44) represented 95.6% and families with PKD2 (n = 2) 4.4% of all families investigated (n = 46). Our clinical analysis, yet based only on a limited number of PKD2 subjects, does not definitely support the concept of a milder phenotype and prognosis in PKD2 versus PKD1 patients, in terms of mean age of diagnosis (29 vs. 29 years), mean age at onset of arterial hypertension (33 vs. 33 years), more favourable renal function or ultrasound findings.